About Neuro-endocrine Carcinoma

One of many forms of cancer is aggressive and devastating neuro-endocrine carcinoma of the colon. The worst feature of this disease is that it is usually detected in advanced stages, at which it is often difficult to treat.

Neuroendocrine colon cancer symptoms become visible only in the advanced stages, so the patient survival rate diminishes. Malignant tumors are mostly detected with remote metastases. Most recent studies show that in almost all cases of neuroendocrine cancer patient's death occurs.

Research findings are pessimistic, the final results of this type of cancer are the same, regardless of age or sex of sick person or location of the tumor. Although neuroendocrine carcinoma of the colon depends on the stage where the tumor, generally patients in stages 1 and 2 of the disease do not suffer from this type of colon cancer (neuroendocrine). In most cases where the tumor is in stage 3 or 4, is very difficult to determine if it is this form of cancer.

Unfortunately, medical science failed to develop any appropriate method to deal with this particular type of cancer. A technique that could use the method of immunohistochemical staining. This method helps doctors to determine the severity of colon cancer and helps determine neuroendocrine useful drug for treating and improving it. Colorarii immunohistochemical method is used specifically for neuroendocrine markers. This involves staining tumor with a monoclonal antibody-80, which will help identify the quantum of neuroendocrine differentiation and the nature of damage to the health of patients.

Unfortunately, neuroendocrine cancer of the colon has a good prognosis and surgery is often powerless against this disease.
For these reasons it is necessary to monitor population health status, so as to take appropriate measures since the first symptoms of illness.

More info HERE